Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,650.00
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 83.00 (5.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 Reverses Three Days Of Gains

Tue, 28th Apr 2015 16:05

LONDON (Alliance News) - The FTSE 100 ended lower Tuesday, reversing the gains made in the previous three sessions, as an equities sell-off in the US overnight fed through into the European session.

London's blue-chip index hit a fresh record intraday high on Monday, but remains susceptible to pullbacks amid investor nerves about the UK election that's hurting sectors like energy and housebuilders in particular, as well as the ongoing standoff between Greece and its creditors.

The FTSE 100 ended down 1.0% at 7,030.53, while the FTSE 250 closed down 0.7% at 17,659.39, and the AIM All-Share index closed down 0.2% at 753.85.

Europe's main indices fell further, with CAC 40 in Paris down 1.8% and the DAX 30 in Frankfurt down 1.9%.

When the European equity markets closed, Wall Street was mixed as indices started taking back earlier losses. The DJIA and the S&P 500 were up 0.1% and the Nasdaq Composite was still down 0.1%. The indices had dropped 0.2%, 0.4% and 0.6%, respectively, on Monday.

UK economic growth slowed more than expected in the first quarter, a preliminary estimate published by the Office for National Statistics revealed. Gross domestic product expanded 0.3% sequentially in the three months to end-March, the slowest growth since the fourth quarter of 2012. The growth rate was forecast to slow to 0.5% from 0.6% logged in the fourth quarter of 2014.

However, the preliminary estimates of UK first quarter growth are likely to be upgraded as the services sector may have grown better than expected, the British Chambers of Commerce said.

Output of the dominant service sector gained 0.5%. Nonetheless, it was slower than the prior quarter's 0.9% growth. Meanwhile, construction and production declined 1.6% and 0.1%. Agriculture output was down 0.2%.

"Although we expected a slowdown in GDP growth, following weak construction and production figures, the scale of the decline estimated by the ONS understates the true momentum in the economy," BCC Chief Economist David Kern said.

"It is likely that the services sector rose by more than 0.5% - in particular we are sceptical that business and financial services output was broadly flat in the quarter. It would not be surprising if this estimate was upgraded in due course," he added.

Greece's troubles remained in the spotlight after Prime Minister Alexis Tsipras warned that he would hold a referendum if international creditors insisted on a "vicious circle of austerity" as the key to unlocking urgently needed bailout money, the Financial Times reported.

Although there were "great possibilities for winning this negotiation", Tsipras said he would go directly to the Greek people if the terms were unacceptable to Athens. "If the solution offered goes beyond our mandate, it will have to be endorsed by the people," the FT quoted him saying in a late night interview with Star Television.

CMC Markets analyst Jasper Lawler believes that the current situation in Greece cannot continue as it is.

"It's hard to imagine the Greek people effectively voting for the country to default or leave the Eurozone, but it's not like staying in the Eurozone is doing them much good at the moment. Local government accounts and public pensions are being plundered just to make debt payments, a situation that can't, and shouldn't, carry on for long," Lawler says.

The first quarter earnings season was in full swing in London Tuesday.

Standard Chartered was amongst the worst-performing stocks in the FTSE 100, closing down 3.2%, after the emerging markets bank reported a 22% drop in first quarter pretax profit, due to pressure on operating income and higher charges for bad loans. It said it made a USD1.47 billion pretax profit in the quarter ended March 31, compared with USD1.88 billion a year earlier.

The lender's results for the first quarter follow a tough year for the bank, which has been hurt by weaker sentiment towards emerging markets, lower commodity prices, and low interest rates set by central banks. Tougher regulations following the global financial crisis of 2007-09 have increased costs for the sector as a whole, while a UK levy on banks' global balance sheets has raised questions about whether the London-headquartered emerging markets bank might be better off if it moved out of the UK.

St James's Place, down 2.8%, closed lower despite reporting an increase in funds under management in the first quarter of its financial year, after taking in GBP1.30 billion of net inflows, boosted by higher limits for individual savings accounts and greater flexibility for people saving for retirement in the UK.

London's mining sector provided some of the support for the FTSE 100 as commodity prices rose. Gold miners Fresnillo, up 2.1%, and Randgold Resources, up 1.0%, climbed on the back of a rise in gold prices as investors headed to the safe haven amid the equity market decline. The yellow metal was trading at USD1,212.40 an ounce when the London equity markets closed.

In the FTSE 250, Acacia Mining, up 3.7%, and Centamin, up 3.4%, were two of the three best performing stocks.

BP closed down 0.2% having been higher for most of the day. The oil and gas major said its pretax profit for the first quarter of 2015 after its exploration and production division was hit by the lowest quarterly oil price since the start of 2009, and by reduced activity, partially offset by higher earnings at the division which produces fuels and lubricants.

BP reported a pretax profit of USD2.27 billion for the first quarter of 2015, down from USD5.27 billion a year earlier, as revenue tumbled to USD54.92 billion from USD92.98 billion.

However, analysts at Liberum noted that BP's underlying replacement cost profit of USD2.58 billion, a figure stripping out non-operating items and fair value accounting effects, came in well ahead of consensus of USD1.28 billion and Liberum's expectation of USD1.59 billion.

FTSE 250-listed Allied Minds ended down 3.0% after it reported a wider loss for 2014 as it spent more on research and development, even though its key value measure rose strongly. It reported a net loss of USD45.5 million for 2014, compared with a loss of USD34.5 million a year earlier, as a rise in both R&D and selling, general and administrative expenses more than offset a rise in revenue to USD7.7 million from USD2.9 million.

Pinnacle Technology closed up 26% as the best performer in the AIM All-Share index. The company said it had raised about GBP0.9 million by placing 13.2 million new shares at 6.5 pence each, a placing that was done to facilitate a strategic investment by MXC Capital.

MXC said it subscribed for 5.9 million of the placing shares, which gives it a 10% stake in Pinnacle's enlarged share capital. It said it has also been granted seven-year warrants over a further 5% of Pinnacle's share capital. Pinnacle's shares closed at 7.10p. MXC Capital shares closed up 5.4%.

In the economic calendar Wednesday, the eurozone economic bulletin is released at 1000 BST along with business and economic sentiment survey results. The German consumer price index reading is at 1300 BST, before US GDP at 1330 BST and pending home sales at 1500 BST. After the close of London stock markets, the US Federal Reserve will announce its interest decision at 1900 BST.

In another busy UK corporate calendar, there are first-quarter interim management statements from Next, British American Tobacco, Weir Group, Barclays, London Stock Exchange Group and TSB Banking Group. Home Retail Group issues full-year results as does online fashion retailer N Brown, while Redefine International and Spirit Pub Company report half year results. Standard Life issues a trading statement and Antofagasta releases a first quarter production report. GlaxoSmithKline reports first quarter results at 1200 BST.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.